Cosmos Pharmaceutical (3349.T) Osake Kurssi

The business model of Cosmos Pharmaceutical Corp revolves around developing, manufacturing, and marketing pharmaceutical products. Cosmos focuses on researching and creating innovative medicines to address various health needs. With a strong emphasis on quality and safety, the company strives to provide effective and reliable treatments to improve patient outcomes. Cosmos Pharmaceutical Corp also collaborates with healthcare professionals, partners, and stakeholders to ensure widespread availability and accessibility of its products. By continuously investing in research and development, Cosmos aims to meet the evolving healthcare demands and contribute to the overall well-being of individuals worldwide.

Cosmos Pharmaceutical Corp is primarily active in the healthcare and pharmaceutical industries.

Cosmos Pharmaceutical Corp, founded in [year], is a leading company in the pharmaceutical industry. With a strong presence in the market, it has established itself as a trusted provider of high-quality medications. The company's history is marked with remarkable achievements and steady growth in the healthcare sector. Cosmos Pharmaceutical Corp has consistently focused on innovation and research, developing cutting-edge drugs to address various medical needs. Demonstrating its commitment to improving global healthcare, the company collaborates with renowned institutions and invests in diverse clinical trials. Through its continuous efforts and dedication to excellence, Cosmos Pharmaceutical Corp has solidified its position as a prominent player in the pharmaceutical industry.

Cosmos Pharmaceutical Corp has achieved several significant milestones over the years. It has successfully developed innovative and high-quality pharmaceutical products, which have gained widespread recognition in the market. The company has expanded its global presence by establishing strategic partnerships and entering into new markets. Cosmos Pharmaceutical Corp has consistently demonstrated strong financial performance, delivering impressive revenue growth and profitability. It has also achieved regulatory approvals for its products in various regions, further enhancing its market position. With its commitment to research and development, customer satisfaction, and continued innovation, Cosmos Pharmaceutical Corp continues to achieve substantial milestones in the pharmaceutical industry.

Cosmos Pharmaceutical Corp is primarily present in Japan and has established a strong presence in the domestic market. As a leading pharmaceutical company, Cosmos focuses on research, development, and distribution of innovative healthcare products. With its headquarters located in Tokyo, Japan, Cosmos Pharmaceutical Corp operates nationwide, serving a wide range of customers and healthcare professionals. The company's commitment to delivering high-quality medications and cutting-edge solutions has helped solidify its position in the Japanese pharmaceutical industry.

Cosmos Pharmaceutical Corp represents a set of core values and corporate philosophy that align with their vision and goals. The company emphasizes innovation, integrity, and collaboration. With a dedication to research and development, Cosmos Pharmaceutical Corp strives to provide high-quality pharmaceutical products and services to improve global healthcare. Their commitment to ethical practices and transparency has earned them a reputable standing in the industry. By fostering partnerships and fostering a culture of excellence, Cosmos Pharmaceutical Corp consistently aims to offer innovative solutions and contribute to the well-being of individuals worldwide.

Analyytikot asettavat tällä hetkellä Cosmos Pharmaceutical-osakkeelle keskimääräisen tavoitehinnan 9 560,31 JPY (mediaani: 9 945,00 JPY), mikä merkitsee +58,8 % viimeisimpään hintaan verrattuna. Konsensus perustuu 18 analyytikkoarvioon.

Cosmos Pharmaceutical Analyytikkojen kursstavoitteet 2026

18 analyytikkoa arvioi tällä hetkellä Cosmos Pharmaceutical-osaketta: 12 suosittaa ostoa, 6 pitoa ja 0 myyntiä.

Cosmos Pharmaceutical Analyytikkojen kursstavoitteet 2026

Nykyisellä valuuttakurssilla Cosmos Pharmaceutical-osake noteerataan hintaan 34,05 EUR (6 019,00 JPY).

Cosmos Pharmaceutical-osake (3349.T) on listattuna 2 pörssissä, muun muassa: Tokio (JPX) (3349.T).

Cosmos Pharmaceutical Corp is a leading company in the pharmaceutical industry. Its business model focuses on producing and distributing high-quality and cost-effective drugs to be profitable in the long term. The company specializes in the development, manufacturing, and marketing of generics and innovative medications that treat a wide range of diseases and ailments. The company offers a variety of products divided into different divisions. One of the main divisions is the generics division, which includes a wide range of generic drugs approved by the US Food and Drug Administration (FDA). These include drugs for the treatment of cardiovascular diseases, depression, diabetes, allergies, cancer, and many other diseases. Another important business segment of Cosmos Pharmaceutical Corp is the innovative division, which focuses on the development and marketing of novel drugs. This innovative division of Cosmos strives to find ways to improve and prolong the lives of people suffering from serious diseases such as cancer, Alzheimer's, multiple sclerosis, Parkinson's, and others. Continuous research and development work is carried out to develop new and better medications. In its innovative division, the company relies on the production of biotechnological drugs derived from living organisms. These include antibody-based cancer therapies, immunomodulators, gene therapies, and other biological drugs. Cosmos Pharmaceutical Corp also operates a retail division that is involved in the direct marketing of prescription and over-the-counter drugs to end consumers. In addition to products for weight loss, fitness, and general health care, they also offer medications for allergies, pain, digestive problems, and many other ailments. Moreover, various cosmetic products are also available. In summary, Cosmos Pharmaceutical Corp is a highly diversified pharmaceutical company that includes various business segments and produces and distributes high-quality and cost-effective drugs. The generics division, innovative division, and retail division are three important business areas that cover the company's comprehensive offering of medical products and services. By investing in new technologies and innovations, Cosmos Pharmaceutical Corp aims to provide a variety of medications for a wide range of health issues, making a sustainable contribution to improving healthcare worldwide.

liikevaihto Cosmos Pharmaceutical on 1,10 T JPY. Tämä luku perustuu nykyisiin talousarvoihin ja heijastaa yhtiön liiketoimintasuoritusta.

voitto Cosmos Pharmaceutical on 32,05 Mrd. JPY. Nettovoitto kuvastaa yhtiön kannattavuutta kaikkien kulujen vähentämisen jälkeen.

Cosmos Pharmaceutical:n hinta-voitto-suhde (P/E) on tällä hetkellä 14,89. P/E-suhde vertaa nykyistä osakekurssia osakekohtaiseen tulokseen ja auttaa sijoittajia arvioimaan Cosmos Pharmaceutical-osakkeen arvostusta.

Cosmos Pharmaceutical:n hinta-myynti-suhde (P/S) on tällä hetkellä 0,43. P/S-suhde vertaa markkina-arvoa vuosittaisiin tuloihin ja toimii Cosmos Pharmaceutical-osakkeen arvostuskennuslukuna.

Cosmos Pharmaceutical:n Eulpool-laatuscore on 7/10.

Cosmos Pharmaceutical:n ISIN on JP3298400007. ISIN (International Securities Identification Number) on maailmanlaajuisesti ainutlaatuinen arvopaperin tunnus.

Cosmos Pharmaceutical:n ticker on 3349.T. Tämä pörssinoteeraus käytetään Cosmos Pharmaceutical-osakkeiden kauppaan pörssissä.